Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Oral Tracking
  • 1.2.3 Vein Tracking
• 1.3 Market by Application
  • 1.3.1 Global Radiopharmaceutical Solutions Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Health Systems
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Radiopharmaceutical Solutions Market Perspective (2017-2028)
• 2.2 Radiopharmaceutical Solutions Growth Trends by Region
  • 2.2.1 Radiopharmaceutical Solutions Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Radiopharmaceutical Solutions Historic Market Size by Region (2017-2022)
  • 2.2.3 Radiopharmaceutical Solutions Forecasted Market Size by Region (2023-2028)
• 2.3 Radiopharmaceutical Solutions Market Dynamics
  • 2.3.1 Radiopharmaceutical Solutions Industry Trends
  • 2.3.2 Radiopharmaceutical Solutions Market Drivers
  • 2.3.3 Radiopharmaceutical Solutions Market Challenges
  • 2.3.4 Radiopharmaceutical Solutions Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Radiopharmaceutical Solutions Players by Revenue
  • 3.1.1 Global Top Radiopharmaceutical Solutions Players by Revenue (2017-2022)
  • 3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Players (2017-2022)
• 3.2 Global Radiopharmaceutical Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Radiopharmaceutical Solutions Revenue
• 3.4 Global Radiopharmaceutical Solutions Market Concentration Ratio
  • 3.4.1 Global Radiopharmaceutical Solutions Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Solutions Revenue in 2021
• 3.5 Radiopharmaceutical Solutions Key Players Head office and Area Served
• 3.6 Key Players Radiopharmaceutical Solutions Product Solution and Service
• 3.7 Date of Enter into Radiopharmaceutical Solutions Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Radiopharmaceutical Solutions Breakdown Data by Type

• 4.1 Global Radiopharmaceutical Solutions Historic Market Size by Type (2017-2022)
• 4.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2023-2028)

5 Radiopharmaceutical Solutions Breakdown Data by Application

• 5.1 Global Radiopharmaceutical Solutions Historic Market Size by Application (2017-2022)
• 5.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Radiopharmaceutical Solutions Market Size (2017-2028)
• 6.2 North America Radiopharmaceutical Solutions Market Size by Country (2017-2022)
• 6.3 North America Radiopharmaceutical Solutions Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe Radiopharmaceutical Solutions Market Size (2017-2028)
• 7.2 Europe Radiopharmaceutical Solutions Market Size by Country (2017-2022)
• 7.3 Europe Radiopharmaceutical Solutions Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Radiopharmaceutical Solutions Market Size (2017-2028)
• 8.2 Asia-Pacific Radiopharmaceutical Solutions Market Size by Country (2017-2022)
• 8.3 Asia-Pacific Radiopharmaceutical Solutions Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America Radiopharmaceutical Solutions Market Size (2017-2028)
• 9.2 Latin America Radiopharmaceutical Solutions Market Size by Country (2017-2022)
• 9.3 Latin America Radiopharmaceutical Solutions Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Radiopharmaceutical Solutions Market Size (2017-2028)
• 10.2 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2017-2022)
• 10.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 IBA
  • 11.1.1 IBA Company Detail
  • 11.1.2 IBA Business Overview
  • 11.1.3 IBA Radiopharmaceutical Solutions Introduction
  • 11.1.4 IBA Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.1.5 IBA Recent Development
• 11.2 GE Healthcare
  • 11.2.1 GE Healthcare Company Detail
  • 11.2.2 GE Healthcare Business Overview
  • 11.2.3 GE Healthcare Radiopharmaceutical Solutions Introduction
  • 11.2.4 GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.2.5 GE Healthcare Recent Development
• 11.3 Actinium Pharmaceuticals
  • 11.3.1 Actinium Pharmaceuticals Company Detail
  • 11.3.2 Actinium Pharmaceuticals Business Overview
  • 11.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Introduction
  • 11.3.4 Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.3.5 Actinium Pharmaceuticals Recent Development
• 11.4 Alseres Pharmaceuticals
  • 11.4.1 Alseres Pharmaceuticals Company Detail
  • 11.4.2 Alseres Pharmaceuticals Business Overview
  • 11.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Introduction
  • 11.4.4 Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.4.5 Alseres Pharmaceuticals Recent Development
• 11.5 Cardinal Health
  • 11.5.1 Cardinal Health Company Detail
  • 11.5.2 Cardinal Health Business Overview
  • 11.5.3 Cardinal Health Radiopharmaceutical Solutions Introduction
  • 11.5.4 Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.5.5 Cardinal Health Recent Development
• 11.6 Jubilant Pharma
  • 11.6.1 Jubilant Pharma Company Detail
  • 11.6.2 Jubilant Pharma Business Overview
  • 11.6.3 Jubilant Pharma Radiopharmaceutical Solutions Introduction
  • 11.6.4 Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.6.5 Jubilant Pharma Recent Development
• 11.7 Central Research Laboratories
  • 11.7.1 Central Research Laboratories Company Detail
  • 11.7.2 Central Research Laboratories Business Overview
  • 11.7.3 Central Research Laboratories Radiopharmaceutical Solutions Introduction
  • 11.7.4 Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.7.5 Central Research Laboratories Recent Development
• 11.8 Cyclomedica
  • 11.8.1 Cyclomedica Company Detail
  • 11.8.2 Cyclomedica Business Overview
  • 11.8.3 Cyclomedica Radiopharmaceutical Solutions Introduction
  • 11.8.4 Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.8.5 Cyclomedica Recent Development
• 11.9 Bracco
  • 11.9.1 Bracco Company Detail
  • 11.9.2 Bracco Business Overview
  • 11.9.3 Bracco Radiopharmaceutical Solutions Introduction
  • 11.9.4 Bracco Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.9.5 Bracco Recent Development
• 11.10 Eckert & Ziegler Radiopharma
  • 11.10.1 Eckert & Ziegler Radiopharma Company Detail
  • 11.10.2 Eckert & Ziegler Radiopharma Business Overview
  • 11.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Introduction
  • 11.10.4 Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2017-2022)
  • 11.10.5 Eckert & Ziegler Radiopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Summary:

Industry Insights
The global Radiopharmaceutical Solutions market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oral Tracking accounting for % of the Radiopharmaceutical Solutions global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Radiopharmaceutical Solutions market size is valued at US$ million in 2021, while the North America and Europe Radiopharmaceutical Solutions are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Radiopharmaceutical Solutions landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radiopharmaceutical Solutions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Radiopharmaceutical Solutions market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Radiopharmaceutical Solutions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Radiopharmaceutical Solutions market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Radiopharmaceutical Solutions market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Radiopharmaceutical Solutions Breakdown Data by Type
Oral Tracking
Vein Tracking
Radiopharmaceutical Solutions Breakdown Data by Application
Hospitals
Health Systems
Others
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
IBA
GE Healthcare
Actinium Pharmaceuticals
Alseres Pharmaceuticals
Cardinal Health
Jubilant Pharma
Central Research Laboratories
Cyclomedica
Bracco
Eckert & Ziegler Radiopharma
Frequently Asked Questions
What factors will challenge the Radiopharmaceutical Solutions market growth?
Which end-use segment will expand at the fastest CAGR in the Radiopharmaceutical Solutions market?
Which are the emerging players in the Radiopharmaceutical Solutions market?
How concentrated is the Radiopharmaceutical Solutions market?
Which factors are positively contributing to the Radiopharmaceutical Solutions market growth?
Which are the novel product innovations in the Radiopharmaceutical Solutions market?
Which product segment will emerge as the most lucrative in the Radiopharmaceutical Solutions market?
Which factors are increasing the competition in the Radiopharmaceutical Solutions market?
Which are the strategic measures taken by the Radiopharmaceutical Solutions industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Radiopharmaceutical Solutions market in the coming years?